Advanced Aesthetic Technologies, Inc.'s Algeness(R) Chosen as a Top Finalist in Prestigious Terra2 Solution Skin Health Innovation Competition
PR88219
BROOKLINE, Mass., Feb. 24, 2021 /PRNewswire=KYODO JBN/ --
Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant
technology, is proud to announce that AAT and our lead product Algeness(R) were
selected as one of the top two finalists in the recent Terra2 Solutions Skin
Health Innovation Competition, finishing as the top aesthetic innovation and
second overall in this prestigious, global event.
Logo - https://mma.prnewswire.com/media/1443163/Algeness_Logo.jpg
As part of their commitment to investing in and supporting the growth of
innovative skin health competitions, Gore Range Capital partnered with Terra2
Solutions, a global think tank, and DermX Media Group, a leader in dermatology
education, to host the Terra2 Solutions Skin Health Innovation Competition. The
finals of the competition were held during the recent 18th Annual Winter
Clinical Dermatology Conference-Hawaii(R) (WC21) that was held virtually this
year and attracted 3,700 attendees.
Doug Abel, CEO of AAT, commented, "We were very honored that Algeness(R) was
invited to participate in this prestigious competition, pleased to be initially
selected as one of the top four semifinalists to present during WC21, and
delighted to finish as one of the top two as selected by a group of industry
leaders and highly respected physicians. This notable recognition from
potential customers and investors underscores the unique advantages of the
Algeness(R) technology as a differentiator in the global dermal filler market."
Participating companies were invited to present to a panel of expert judges and
providers in the fields of clinical dermatology, aesthetic medicine, and other
aspects of skin health, and executive leaders of pharmaceutical, medical
device, diagnostic, and IT companies. Four semifinalists including AAT
presented their pitch videos to the entire audience during the meeting, and the
two finalists, AAT and Mindera Corporation were given the opportunity to
present a live pitch to be followed by questions from the panel of judges.
"The dermal filler market is one of the most attractive segments in healthcare.
Advanced Aesthetic Technologies has the know-how, the assets, and the
capabilities necessary to bring innovative and differentiated products to this
market. The recent Terra2 Solutions Skin Health Competition recognized AAT's
Algeness(R) as a finalist among the most innovative technologies in medical
skin health in the world," said Humberto Antunes, Founder of Terra2 Solutions,
a Partner at Gore Range, and former global CEO of Galderma Laboratories.
According to board certified dermatologist Valerie Callender, MD, FAAD, of
Callender Dermatology and Cosmetic Center in Glenn Dale, MD, who served as one
of the judges for the Terra2 Solutions competition, "The unique attributes of
Algeness(R) as presented will provide an important addition to the dermal
filler market, filling a need for a product that offers a differentiated
capability for achieving facial shape and contour definition and the potential
for an outstanding safety profile."
Algeness(R) is a patented family of fully resorbable injectable gel implant
dermal fillers that are 100% natural, providing advantages in terms of safety,
skin rejuvenation, and natural looking results both at rest and during facial
movement. Typical clinical advantages include minimal swelling upon injection
and immediately visible results. Algeness(R) holds a CE Mark and is currently
distributed in over 30 countries worldwide. AAT has begun efforts to obtain US
FDA approval.
About Terra2 Solutions Skin Health Innovation Competition
The Terra2 Solutions Skin Health Innovation Competition showcases companies
developing new treatments, diagnostic capabilities, and technologies to improve
the health of our skin. The Competition is an opportunity for Winter Clinical
Dermatology Conference-Hawaii(R) participants to learn about emerging solutions
in clinical dermatology and aesthetic medicine.
https://www.gorerangecapital.com/innovationcompetition
About Advanced Aesthetic Technologies, Inc.
AAT is a fast growing, global corporation developing new technologies for
aesthetic medicine. Our lead products, the Algeness(R) family of injectable
implants, are the culmination of more than 10 years of scientific and clinical
research and were developed with the goal of providing aesthetic injectors
advances in the ability to achieve deep structural support, clean definition,
and exceptional clinical outcomes where the result at the time of treatment is
the final outcome. Algeness(R) is a 100% natural and biodegradable filler based
on purified agarose with a differentiated clinical and safety performance
profile. AAT continuously invests in research and product development to expand
the scientific knowledge on Algeness(R) and agarose as well as in pursuit of
new and innovative technologies to enhance aesthetic medicine and expand our
product portfolio. Algeness(R) is CE Marked, has multiple additional country
level registrations, and is currently available in over 30 countries. AAT is in
the process of pursuing registration in the US through the FDA and also in
China through the partnership with Lanzhou Biotechnique Development Co., LTD
(Lanzhou) and their parent company China National Biotec Group Co., LTD (CNBG).
About the Winter Clinical Dermatology Conference
For the past 18 years, the Winter Clinical Dermatology Conference-Hawaii(R), a
continuing medical education (CME) event, has provided practitioners, including
dermatologists, dermatologic surgeons, residents, fellows, physician assistants
and nurse practitioners, with a therapeutic update based on real-life
experience of the faculty. https://fallclinical.health
About Terra2 Solutions
Terra2 Solutions is a global think tank focused on exploring and designing
solutions that address the emerging healthcare issues arising from our
progression towards Terra2. Traditional social, demographic, and institutional
dynamics that have driven and defined society for the last 2,500 years is
rapidly changing. This disruption is driven by shifts in age and economic
demographics, globalization trends, and rapid digitalization. The Sars-2-Cov
pandemic has accelerated these trends and created a growing need for
forward-looking products, technologies, and business models.
http://www.terra2solutions.com/
About Gore Range Capital
Gore Range Capital is a venture capital firm investing in early-stage
healthcare businesses with a focus on skin health. The firm blends the hands-on
approach of operationally focused private equity with the early-stage guidance
needed in venture capital. https://www.gorerangecapital.com/
Contact: filler@algeness.com
SOURCE: Advanced Aesthetic Technologies, Inc.
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。